A Phase 2 Multi-center, Open-label, Single Arm Study of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05997056

Title field or adapter rule

{'original_value': 'A Phase 2 Multi-center, Open-label, Single Arm Study of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:27.042352+00:00

Published At

2026-08-25T00:00:00+00:00

Record Updated At

2026-08-25

Results Posted At

2026-08-25

Source Retrieved At

2026-10-31T22:17:58.991924+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Neuroendocrine Tumors", "NET", "Pancreatic Neuroendocrine Tumor", "Gastrointestinal Neuroendocrine Tumor", "Pulmonary Neuroendocrine Tumor"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-08-25", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT05997056"

protocolSection.identificationModule.officialTitle

"A Phase 2 Multi-center, Open-label, Single Arm Study of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2026-08-25", "type": "ACTUAL"}

Study condition terms

• Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)
• NET (protocolSection.conditionsModule.conditions)
• Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)
• Gastrointestinal Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)
• Pulmonary Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['neuroendocrine tumors'], 'description': 'Prospective phase 2 single arm, open-label, multi-institutional study to determine the efficacy and safety prospective of nab-sirolimus administered by IV infusion', 'name': 'nab-sirolimus', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• nab-sirolimus (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.